About this trial
Glaucoma is a leading cause of irreversible blindness worldwide, with a higher burden in low- and middle-income countries such as Nepal, where public awareness and treatment adherence remain poor. Lifelong adherence to treatment is important to prevent disease progression but still non adherence remains common.
This is a mixed method study which aims to evaluate the effectiveness of structured glaucoma awareness program in improving treatment adherence among glaucoma patients attending a tertiary eye hospital in Nepal. Quantitative assessment will measure changes in treatment adherence using Medication Adherence Scale at baseline and three months post intervention. A qualitative component will explore participants' perceptions of glaucoma program and suggestions for improvement through semi-structured interviews.
Eligibility criteria
Qualifiers
Adults aged ≥18 years
Diagnosed with glaucoma
Attending follow-up at the study hospital
Able to provide informed consent
Disqualifiers
None
Trial design
Treatments tested in this trial
- Glaucoma awareness and patient education program
Treatment groups
Locations
Sponsors and collaborators
Seva Canada Society
Lead sponsor
Reiyukai Eiko Masunaga Eye Hospital (REMEH)
Collaborator
Pragyaan Sustainable Health Outcomes Foundation
Collaborator